Triple-Drug Therapy May Improve Sugar Control in Adults with Diabetes
Journal: Annals of Internal Medicine (2001)

Summaries for Patients1 May 2001Triple-Drug Therapy May Improve Sugar Control in Adults with DiabetesSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-134-9_Part_1-200105010-00005 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?Diabetes is a chronic condition that can lead to damage of the eyes, heart, kidneys, and nerves. People with diabetes have persistent elevations in blood sugar levels. Treatments that can lower blood sugar levels include diet, exercise, insulin injections, and medications. Metformin and sulfonylurea are types of medications commonly used to treat adults with diabetes. Many diabetic adults take several medications but still have trouble controlling their sugar levels. A newer type of medication, thiazolidinediones, can help control blood sugar; it is not clear, however, whether these newer ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “The Effect of a Thiazolidinedione Drug, Troglitazone, on Glycemia in Patients with Type 2 Diabetes Mellitus Poorly Controlled with Sulfonylurea and Metformin. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.” It is in the 1 May 2001 issue of Annals of Internal Medicine (volume 134, pages 737-745). The authors are JF Yale, TR Valiquett, MN Ghazzi, JK Owens-Grillo, RW Whitcomb, and HL Foyt, for the Troglitazone Triple-Therapy Study Group.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoThe Effect of a Thiazolidinedione Drug, Troglitazone, on Glycemia in Patients with Type 2 Diabetes Mellitus Poorly Controlled with Sulfonylurea and Metformin: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Jean-François Yale , Thomas R. Valiquett , Mahmoud N. Ghazzi , Janet K. Owens-Grillo , Randall W. Whitcomb , Howard L. Foyt , and The Effect of a Thiazolidinedione Drug, Troglitazone, on Glycemia in Patients with Type 2 Diabetes Mellitus Poorly Controlled with Sulfonylurea and Metformin: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Jean-François Yale , Thomas R. Valiquett , Mahmoud N. Ghazzi , Janet K. Owens-Grillo , Randall W. Whitcomb , Howard L. Foyt , and Metrics 1 May 2001Volume 134, Issue 9_Part_1Page: I-2KeywordsBlood sugarDrug regulationDrugsHematologic testsInsulinKidneysLiverNauseaNervesType 2 diabetes ePublished: 1 May 2001 Issue Published: 1 May 2001 Copyright & PermissionsCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...